What’s Propelling Dentsply Sirona Inc (NASDAQ:XRAY) After Higher Shorts Reported?


Investors sentiment increased to 1 in Q1 2019. Its up 0.50, from 0.5 in 2018Q4. It increased, as 0 investors sold DENTSPLY SIRONA Inc. shares while 1 reduced holdings. 0 funds opened positions while 1 raised stakes. 126,026 shares or 12.44% less from 143,929 shares in 2018Q4 were reported.
Cardinal Capital Mngmt invested in 1.03% or 72,754 shares. Cibc Markets Corporation reported 53,272 shares.

Since May 7, 2019, it had 3 insider purchases, and 0 selling transactions for $888,638 activity. 2,720 shares were bought by HOLDEN BETSY D, worth $150,439 on Thursday, June 6. On Tuesday, May 7 Key Daniel P bought $202,152 worth of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) or 3,697 shares.

The stock of Dentsply Sirona Inc (NASDAQ:XRAY) registered an increase of 5.04% in short interest. XRAY’s total short interest was 4.75 million shares in August as published by FINRA. Its up 5.04% from 4.52M shares, reported previously. With 1.62M shares average volume, it will take short sellers 3 days to cover their XRAY’s short positions. The short interest to Dentsply Sirona Inc’s float is 2.16%.

The stock increased 2.08% or $1.09 during the last trading session, reaching $53.37. About 1.57 million shares traded. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has risen 14.17% since August 13, 2018 and is uptrending. It has outperformed by 14.17% the S&P500.

DENTSPLY SIRONA Inc. designs, develops, makes, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company has market cap of $11.97 billion. It operates through two divisions, Dental and Healthcare Consumables; and Technologies. It has a 113.31 P/E ratio. The firm provides dental consumable products, including endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprising dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.


Among 6 analysts covering DENTSPLY SIRONA (NASDAQ:XRAY), 1 have Buy rating, 0 Sell and 5 Hold. Therefore 17% are positive. DENTSPLY SIRONA had 14 analyst reports since February 23, 2019 according to SRatingsIntel. Barclays Capital maintained the stock with “Hold” rating in Friday, March 1 report. As per Monday, March 4, the company rating was maintained by H.C. Wainwright. The firm earned “Neutral” rating on Monday, March 4 by Robert W. Baird. Bank of America maintained it with “Buy” rating and $57 target in Monday, March 18 report. The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has “Neutral” rating given on Tuesday, March 12 by UBS.

More notable recent DENTSPLY SIRONA Inc. (NASDAQ:XRAY) news were published by: Nasdaq.com which released: “Integra Lifesciences’ (IART) Earnings Top Estimates in Q2 – Nasdaq” on July 25, 2019, also Nasdaq.com with their article: “Masimo (MASI) to Report Q2 Earnings: What’s in the Offing? – Nasdaq” published on July 26, 2019, Nasdaq.com published: “DENTSPLY SIRONA (XRAY) Q1 Earnings: What’s in the Cards? – Nasdaq” on April 29, 2019. More interesting news about DENTSPLY SIRONA Inc. (NASDAQ:XRAY) were released by: Nasdaq.com and their article: “DENTSPLY SIRONA (XRAY) Q2 Earnings Beat, Revenues Fall Y/Y – Nasdaq” published on August 02, 2019 as well as Nasdaq.com‘s news article titled: “LabCorp’s (LH) Q2 Earnings Beat Estimates, Margins Fall – Nasdaq” with publication date: July 25, 2019.


Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.